XENE financials

Xenon Pharmaceuticals (XENE) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

XENE income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025$7.50M–-$373.07M-$345.91M-4.36
2024$0.00–-$279.30M-$234.33M-3.01
2023$0.00–-$214.05M-$182.39M-2.73
2022$9.43M–-$129.14M-$124.94M-2.06
2021$18.44M–-$78.99M-$77.09M-1.77
2020$32.17M–-$31.30M-$28.01M-0.81